Search Page

1

Cite

Share

Resveratrol and resveratrol analogues--structure-activity relationship.

Szekeres T, Fritzer-Szekeres M, Saiko P, Jäger W. Szekeres T, et al. Among authors: saiko p. Pharm Res. 2010 Jun;27(6):1042-8. doi: 10.1007/s11095-010-0090-1. Epub 2010 Mar 16. Pharm Res. 2010. PMID: 20232118 Review.

Cite

Share

2

Cite

Share

Chemopreventive effects of resveratrol and resveratrol derivatives.

Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, Jäger W. Szekeres T, et al. Among authors: saiko p. Ann N Y Acad Sci. 2011 Jan;1215:89-95. doi: 10.1111/j.1749-6632.2010.05864.x. Ann N Y Acad Sci. 2011. PMID: 21261645 Review.

Cite

Share

3

Cite

Share

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?

Saiko P, Szakmary A, Jaeger W, Szekeres T. Saiko P, et al. Mutat Res. 2008 Jan-Feb;658(1-2):68-94. doi: 10.1016/j.mrrev.2007.08.004. Epub 2007 Aug 17. Mutat Res. 2008. PMID: 17890139 Review.

Cite

Share

4

Cite

Share

Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?

Saiko P, Horvath Z, Jaeger W, Schott H, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. In Vivo. 2005 Jan-Feb;19(1):205-14. In Vivo. 2005. PMID: 15796176 Free article. Review.

Cite

Share

5

Cite

Share

Methyl-2-arylidene hydrazinecarbodithioates: synthesis and biological activity.

Mahapatra M, Kulandaivelu U, Saiko P, Graser G, Szekeres T, Andrei G, Snoeck R, Balzarini J, Jayaprakash V. Mahapatra M, et al. Among authors: saiko p. Chem Zvesti. 2013;67(6):650-656. doi: 10.2478/s11696-013-0346-4. Epub 2013 Feb 19. Chem Zvesti. 2013. PMID: 32214621 Free PMC article.

Cite

Share

6

Cite

Share

In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.

Kopf S, Viola K, Atanasov AG, Jarukamjorn K, Rarova L, Kretschy N, Teichmann M, Vonach C, Saiko P, Giessrigl B, Huttary N, Raab I, Krieger S, Schumacher M, Diederich M, Strnad M, de Martin R, Szekeres T, Jäger W, Dirsch VM, Mikulits W, Grusch M, Dolznig H, Krupitza G. Kopf S, et al. Among authors: saiko p. Arch Toxicol. 2013 Oct;87(10):1851-61. doi: 10.1007/s00204-013-1045-1. Epub 2013 Mar 30. Arch Toxicol. 2013. PMID: 23543012

Cite

Share

7

Cite

Share

N-hydroxy-N'-aminoguanidines as anti-cancer lead molecule: QSAR, synthesis and biological evaluation.

Basu A, Sinha BN, Saiko P, Graser G, Szekeres T. Basu A, et al. Among authors: saiko p. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3324-8. doi: 10.1016/j.bmcl.2011.04.009. Epub 2011 Apr 9. Bioorg Med Chem Lett. 2011. PMID: 21536434

Cite

Share

8

Cite

Share

Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.

Nguyen CH, Huttary N, Atanasov AG, Chatuphonprasert W, Brenner S, Fristiohady A, Hong J, Stadler S, Holzner S, Milovanovic D, Dirsch VM, Kopp B, Saiko P, Krenn L, Jäger W, Krupitza G. Nguyen CH, et al. Among authors: saiko p. Int J Oncol. 2017 May;50(5):1879-1888. doi: 10.3892/ijo.2017.3956. Epub 2017 Apr 7. Int J Oncol. 2017. PMID: 28393180

Cite

Share

9

Cite

Share

Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.

Saiko P, Graser G, Giessrigl B, Steinmann MT, Schuster H, Lackner A, Grusch M, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. Invest New Drugs. 2013 Oct;31(5):1115-24. doi: 10.1007/s10637-013-0009-x. Epub 2013 Aug 14. Invest New Drugs. 2013. PMID: 23943154

Cite

Share

10

Cite

Share

Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study.

Ferk F, Kundi M, Brath H, Szekeres T, Al-Serori H, Mišík M, Saiko P, Marculescu R, Wagner KH, Knasmueller S. Ferk F, et al. Among authors: saiko p. Mol Nutr Food Res. 2018 Feb;62(4). doi: 10.1002/mnfr.201700482. Epub 2018 Jan 15. Mol Nutr Food Res. 2018. PMID: 29193677 Clinical Trial.

Cite

Share